| Indiana University, Ph.D. | |
| Organic chemistry |
Dr. Robert Zelle has over 20 years of drug discovery and development experience and currently serves as Vice President, Drug Development of Concert Pharmaceuticals, Inc. Prior to joining Concert in July 2006 he held key positions at Scion Pharmaceuticals, Acusphere, Vertex Pharmaceuticals and Abbott Laboratories. Before Concert, Dr. Zelle founded Bell Rock Associates, a pharmaceutical development consulting firm. He also served as Vice President of Chemistry at Scion where he was responsible for discovery chemistry, manufacturing, intellectual property and regulatory submissions. Before Scion, he was Senior Director of Regulatory Affairs and Product Development at Acusphere. In this role he was responsible for regulatory affairs, quality assurance, quality control and preclinical testing. Dr. Zelle has been granted 24 U.S. patents with numerous pending U.S. applications. Dr. Zelle has had extensive experience filing investigational new drug (IND) applications and bringing compounds into clinical development.
